Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SGX/T14 stock hub

SGX/T14 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SGX/T14is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.3B

Singapore Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SGX/T14

In the news

Latest news · SGX/T14

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 18.2P50 25.4P75 35.6

Trailing P/E13.1

P25 15.6P50 22.4P75 35.2

ROE27.5

P25 -8.4P50 6.3P75 7.7

ROIC18.2

P25 -2.6P50 4P75 8.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SGX/T14 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

CNY

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	SG
Employees	3,890
Employees Change	-294%
Employees Change Percent	-5.98
Enterprise value	$5.2B
Exchange	Singapore Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100000924
Last refreshed	2026-05-10
Market cap	$5.3B
Price	$3.31
Price currency	USD
Rev Per Employee	239,088.85x
Sector	Healthcare
Sic	2834
Symbol	sgx/T14
Website	https://www.jydrt.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.65%
EV Earnings	12.69x
EV/EBIT	27.18x
EV/EBITDA	24.58x
EV/FCF	66.38x
EV/Sales	5.57x
FCF yield	1.46%
P/B ratio	3.79x
P/E ratio	13.07x
P/S ratio	5.73x
PE Ratio10 Y	19.11x
PE Ratio3 Y	16.74x
PE Ratio5 Y	18.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.5%
EBITDA Margin	22.62%
FCF margin	8.37%
Gross margin	74.49%
Gross Profit	$692.8M
Gross Profit Growth	5.84%
Gross Profit Growth Q	9.54%
Gross Profit Growth3 Y	1.32%
Gross Profit Growth5 Y	6.79%
Net Income	$407.5M
Net Income Growth	-1.61%
Net Income Growth Q	13.24%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	27.06%
Net Income Growth5 Y	25.34%
Pretax Margin	51.13%
Profit Margin	43.81%
Profit Per Employee	$104,747
Profitable Years	18
ROA	5.9
Roa5y	4.67
ROCE	13.42
ROE	27.47
Roe5y	19.9
ROIC	18.21
Roic5y	16.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	22.05%
Cagr15y	16.22%
Cagr1y	81.82%
Cagr20y	21.53%
Cagr3y	27.29%
Cagr5y	41.34%
Div CAGR10	36.18%
Div CAGR3	46.79%
Div CAGR5	61.16%
EPS Growth	-1.91
EPS Growth Q	12.25
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	27.4
EPS Growth5 Y	25.2
FCF Growth	-66.45%
FCF Growth Q	22.4%
FCF Growth3 Y	-15%
FCF Growth5 Y	-2.45%
OCF Growth	-61.47%
OCF Growth Q	18.75%
OCF Growth10 Y	4.93%
OCF Growth3 Y	-12.41%
OCF Growth5 Y	-3.97%
Revenue Growth	-25.45x
Revenue Growth Q	4.12x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-16.39x
Revenue Growth5 Y	-5.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.46
Assets	$2B
Cash	$168.6M
Current Assets	$1.1B
Current Liabilities	$527.2M
Debt	$10.8M
Debt EBITDA	$0.05
Debt Equity	$0.01
Debt FCF	$0.14
Equity	$1.4B
Interest Coverage	111.4
Liabilities	$544.4M
Long Term Assets	$810.4M
Long Term Liabilities	$17.3M
Net Cash	$157.8M
Net Cash By Market Cap	$2.96
Net Cash Growth	-39.6%
Net Debt EBITDA	$-0.75
Net Debt Equity	$-0.11
Net Debt FCF	$-2.03
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$1.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.16
Inventory Turnover	1.11
Net Working Capital	$455.3M
Quick ratio	0.96
Working Capital	$614.2M
Working Capital Turnover	$0.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.31%
Dividend Growth	0%
Dividend Growth Years	8%
Dividend per share	$0.67
Dividend Years	16
Dividend Yield	20.38%
Ex Div Date	2026-01-30
Last Dividend	$0.45
Payout Frequency	Annual
Payout Ratio	131.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	633.48%
1Y total return	81.75%
200-day SMA	3.1
3Y total return	106.29%
50-day SMA	3.28
50-day SMA vs 200-day SMA	50over200
5Y total return	463.96%
All Time High	3.75
All Time High Change	-11.73%
All Time High Date	2026-02-23
All Time Low	0.02
All Time Low Change	20,717.61%
All Time Low Date	1998-08-17
ATR	0.09
Ch YTD	-2.93
High	3.33
High52	3.75
High52 Date	2026-02-23
High52ch	-11.73%
Low	3.29
Low52	2.19
Low52 Date	2025-05-08
Low52ch	51.84%
Ma50ch	1.04%
Price vs 200-day SMA	6.77%
RSI	51.61
RSI Monthly	62.71
RSI Weekly	54.18
Sharpe ratio	1.84x
Sortino ratio	3.39
Total Return	20.07%
Tr YTD	8.72
Tr15y	853.4%
Tr1m	3.44%
Tr1w	-5.97%
Tr3m	-1.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$190.7M
Operating Income Growth	26.29
Operating Income Growth Q	27.48
Operating Income Growth3 Y	6.91
Operating Income Growth5 Y	11.33
Operating margin	20.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	426,532,428%
Net Borrowing	75,382.6
Shares Insiders	1.6%
Shares Institutions	13.14%
Shares Qo Q	-0.11%
Shares Yo Y	0.31%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$77.9M
Average Volume	185,720x
Bv Per Share	1.82
CAPEX	$-20.7M
Ch10y	289.4
Ch15y	341.3
Ch1m	3.44
Ch1w	-5.97
Ch1y	51.14
Ch20y	2,073.3
Ch3m	-1.78
Ch3y	49.1
Ch5y	261.7
Ch6m	9.6
Change	-0.6%
Change From Open	-0.6
Close	3.33
Days Gap	0
Depreciation Amortization	19,630,076.9
Dollar Volume	383,960
Earnings Date	2026-04-30
EBIT	$190.7M
EBITDA	$210.4M
EPS	$0.53
F Score	5
FCF	$77.9M
FCF EV Yield	1.51x
Financing CF	-534,362,322
Fiscal Year End	December
Founded	1,915
Graham Number	2.23092
Graham Upside	-32.6
Income Tax	$71.6M
Investing CF	332,583,086
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2010-06-30
Last Split Type	Forward
Lynch Fair Value	$6.33
Lynch Upside	91.26
Ma150	3.18
Ma150ch	4.12%
Ma20	3.27
Ma20ch	1.22%
Net CF	-103,273,804
Next Earnings Date	2026-08-14
Open	3.33
P FCF Ratio	68.4
P OCF Ratio	54.01
Payment Date	2026-02-12
Position In Range	50
Ppne	210,822,825.2
Price Date	2026-05-08
Price EBITDA	$25.32
Ptbv Ratio	3.94
Relative Volume	0.61x
Revenue	930,055,629x
Tax By Revenue	7.7x
Tax Rate	15.05%
Tr20y	4,840.52%
Tr6m	22.76%
Volume	116,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SGX/T14 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+20.4%

$0.67 annual per share

Payout ratio

+131.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+61.2%

8 consecutive years of growth

Total shareholder yield

+20.1%

Next ex-dividend date: 2026-01-30

Performance

SGX/T14 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SGX/T14?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.1%

Share of float held by funds and institutions

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

SGX/T14 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.6

Neutral momentum band

Price vs 200-day MA

+6.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.84

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SGX/T14

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sgx/T14 stock rating?

sgx/T14 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sgx/T14 analysis?

The full report lives at /stocks/sgx/T14/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sgx/T14?

The latest report frames sgx/T14 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sgx/T14 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.